Unilab’s Sales Rise, but Profits Decline
- Share via
Unilab Corp., the Tarzana-based clinical laboratory testing company, saw its profits tumble 89% in its third quarter compared to a year ago, while its sales rose 31%.
The company posted a $232,000 profit in the third quarter that ended Sept. 30, compared to a $2.1 million profit in the same period a year earlier. Sales in the latest quarter rose to $50.2 million, up from $38.3 million.
For nine months, the company posted a $36.7-million loss, compared to a $4.2-million profit a year ago. Sales for the latest nine months rose 24% to $140.3 million, up from $112.9 million.
The company attributed much of its loss to its recent acquisitions, but said that it had begun cost-cutting. Unilab is the biggest clinical lab testing concern in the state.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
